Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism)

被引:31
作者
Levi, Marcel [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Coagulation; Pregnancy; Disseminated intravascular coagulation; Amniotic fluid embolism; PATHWAY INHIBITOR TFPI; TISSUE FACTOR TF; ABRUPTIO PLACENTAE; MORTALITY; PREGNANCY;
D O I
10.1016/S0049-3848(13)70017-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute coagulopathic peripartum calamities are relatively rare but contribute importantly to maternal morbidity and mortality in the Western world. Abruptio placenta, amniotic fluid embolism, and retained fetal or placental material may lead to fulminant intravascular activation of coagulation which results in thromboembolic complications and consumption coagulopathy causing severe hemorrhage. The central underlying pathophysiological pathway in the coagulopathy associated with these syndromes is the occurrence of tissue factor, released from the placenta and amniotic fluid, in the circulation, in combination with low levels of physiological anticoagulant factors during pregnancy. The diagnosis of DIC may be made trough conventional composite scoring systems employing routine coagulation tests, whereas for the diagnosis of amniotic fluid embolism measurement of insulin like growth factor binding protein-1 seems promising. Therapy is aimed at removing the precipitating factor combined with supportive adjunctive treatment options. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S32 / S34
页数:3
相关论文
共 28 条
[1]  
[Anonymous], 1901, AM J OBSTET GYNECOL
[2]   Tissue factor-dependent blood coagulation is enhanced following delivery irrespective of the mode of delivery [J].
Boer, K. ;
den Hollander, I. A. ;
Meijers, J. C. M. ;
Levi, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (12) :2415-2420
[3]   Massive obstetric haemorrhage [J].
Bonnar, J .
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2000, 14 (01) :1-18
[4]   Abruptio placentae - A "classic" dedicated to Elizabeth Ramsey [J].
Eskes, TKAB .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 75 (01) :63-70
[5]  
Fässler M, 2010, SWISS MED WKLY, V140, P25, DOI smw-12768
[6]   Amniotic fluid embolism: Decreased mortality in a population-based study [J].
Gilbert, WM ;
Danielsen, B .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (06) :973-977
[7]   Incidence and Risk Factors for Amniotic-Fluid Embolism [J].
Knight, Marian ;
Tuffnell, Derek ;
Brocklehurst, Peter ;
Spark, Patsy ;
Kurinczuk, Jennifer J. .
OBSTETRICS AND GYNECOLOGY, 2010, 115 (05) :910-917
[8]   Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium [J].
Kuczynski, J ;
Uszynski, W ;
Zekanowska, E ;
Soszka, T ;
Uszynski, M .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 105 (01) :15-19
[9]   Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism [J].
Legrand, Matthieu ;
Rossignol, Mathias ;
Dreux, Sophie ;
Luton, Dominique ;
Ventre, Chloe ;
Barranger, Emmanuel ;
Laribi, Said ;
Payen, Didier ;
Muller, Francoise .
CRITICAL CARE MEDICINE, 2012, 40 (07) :2059-2063
[10]   Use of Recombinant Factor VIIa in Patients with Amniotic Fluid Embolism A Systematic Review of Case Reports [J].
Leighton, Barbara L. ;
Wall, Michael H. ;
Lockhart, Ellen M. ;
Phillips, Louise E. ;
Zatta, Amanda J. .
ANESTHESIOLOGY, 2011, 115 (06) :1201-1208